Hologic, Inc. (HOLX)
USD 58.46
(-4.59%)
USD 58.46
(-4.59%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 4.02 Billion USD | -2.34% |
| 2023 | 4.12 Billion USD | -1.73% |
| 2022 | 4.19 Billion USD | -10.77% |
| 2021 | 4.7 Billion USD | 4.74% |
| 2020 | 4.48 Billion USD | 3.61% |
| 2019 | 4.33 Billion USD | -9.79% |
| 2018 | 4.8 Billion USD | -7.56% |
| 2017 | 5.19 Billion USD | 0.4% |
| 2016 | 5.17 Billion USD | -7.45% |
| 2015 | 5.59 Billion USD | -11.98% |
| 2014 | 6.35 Billion USD | -10.02% |
| 2013 | 7.05 Billion USD | -6.08% |
| 2012 | 7.51 Billion USD | 144.67% |
| 2011 | 3.07 Billion USD | 4.94% |
| 2010 | 2.92 Billion USD | -7.86% |
| 2009 | 3.17 Billion USD | -9.03% |
| 2008 | 3.49 Billion USD | 1239.99% |
| 2007 | 260.62 Million USD | 4.06% |
| 2006 | 250.45 Million USD | 303.93% |
| 2005 | 62 Million USD | 36.35% |
| 2004 | 45.47 Million USD | 14.62% |
| 2003 | 39.67 Million USD | -5.23% |
| 2002 | 41.86 Million USD | -49.75% |
| 2001 | 83.31 Million USD | -5.42% |
| 2000 | 88.08 Million USD | 246.78% |
| 1999 | 25.4 Million USD | -21.12% |
| 1998 | 32.2 Million USD | 79.89% |
| 1997 | 17.9 Million USD | 13.29% |
| 1996 | 15.8 Million USD | 41.07% |
| 1995 | 11.2 Million USD | 30.23% |
| 1994 | 8.6 Million USD | 45.76% |
| 1993 | 5.9 Million USD | 28.26% |
| 1992 | 4.6 Million USD | 48.39% |
| 1991 | 3.1 Million USD | -32.61% |
| 1990 | 4.6 Million USD | -13.21% |
| 1989 | 5.3 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 3.93 Billion USD | 1.79% |
| 2024 Q4 | 4.02 Billion USD | 2.2% |
| 2024 Q2 | 3.87 Billion USD | 1.42% |
| 2024 Q1 | 3.81 Billion USD | -7.44% |
| 2023 Q3 | 4.15 Billion USD | 0.19% |
| 2023 Q2 | 4.14 Billion USD | -1.19% |
| 2023 Q1 | 4.19 Billion USD | 0.07% |
| 2023 FY | 4.12 Billion USD | -1.73% |
| 2023 Q4 | 4.12 Billion USD | -0.81% |
| 2022 FY | 4.19 Billion USD | -10.77% |
| 2022 Q3 | 4.35 Billion USD | -7.67% |
| 2022 Q4 | 4.19 Billion USD | -3.77% |
| 2022 Q2 | 4.72 Billion USD | -0.93% |
| 2022 Q1 | 4.76 Billion USD | 1.38% |
| 2021 Q1 | 4.28 Billion USD | -4.61% |
| 2021 Q2 | 4.24 Billion USD | -0.76% |
| 2021 Q4 | 4.7 Billion USD | -0.26% |
| 2021 Q3 | 4.71 Billion USD | 10.93% |
| 2021 FY | 4.7 Billion USD | 4.74% |
| 2020 Q1 | 4.05 Billion USD | -6.41% |
| 2020 Q2 | 4.73 Billion USD | 16.68% |
| 2020 Q3 | 4.54 Billion USD | -3.93% |
| 2020 Q4 | 4.48 Billion USD | -1.23% |
| 2020 FY | 4.48 Billion USD | 3.61% |
| 2019 Q4 | 4.33 Billion USD | 0.61% |
| 2019 FY | 4.33 Billion USD | -9.79% |
| 2019 Q2 | 4.36 Billion USD | -3.78% |
| 2019 Q1 | 4.53 Billion USD | -5.52% |
| 2019 Q3 | 4.3 Billion USD | -1.37% |
| 2018 FY | 4.8 Billion USD | -7.56% |
| 2018 Q2 | 4.78 Billion USD | -1.35% |
| 2018 Q4 | 4.8 Billion USD | 3.45% |
| 2018 Q3 | 4.64 Billion USD | -3.07% |
| 2018 Q1 | 4.85 Billion USD | -6.56% |
| 2017 Q4 | 5.19 Billion USD | -1.09% |
| 2017 FY | 5.19 Billion USD | 0.4% |
| 2017 Q1 | 5.1 Billion USD | -1.26% |
| 2017 Q2 | 5.9 Billion USD | 15.66% |
| 2017 Q3 | 5.25 Billion USD | -11.12% |
| 2016 Q4 | 5.17 Billion USD | -1.7% |
| 2016 Q3 | 5.26 Billion USD | 0.42% |
| 2016 Q2 | 5.24 Billion USD | -4.92% |
| 2016 Q1 | 5.51 Billion USD | -1.39% |
| 2016 FY | 5.17 Billion USD | -7.45% |
| 2015 Q4 | 5.59 Billion USD | -5.13% |
| 2015 FY | 5.59 Billion USD | -11.98% |
| 2015 Q2 | 5.86 Billion USD | -1.88% |
| 2015 Q3 | 5.89 Billion USD | 0.52% |
| 2015 Q1 | 5.97 Billion USD | -5.92% |
| 2014 Q1 | 6.53 Billion USD | -7.44% |
| 2014 Q2 | 6.38 Billion USD | -2.32% |
| 2014 Q3 | 6.38 Billion USD | -0.02% |
| 2014 FY | 6.35 Billion USD | -10.02% |
| 2014 Q4 | 6.35 Billion USD | -0.45% |
| 2013 Q3 | 7.33 Billion USD | 0.24% |
| 2013 Q1 | 7.48 Billion USD | -0.42% |
| 2013 Q2 | 7.31 Billion USD | -2.21% |
| 2013 Q4 | 7.05 Billion USD | -3.78% |
| 2013 FY | 7.05 Billion USD | -6.08% |
| 2012 Q4 | 7.51 Billion USD | 148.67% |
| 2012 FY | 7.51 Billion USD | 144.67% |
| 2012 Q3 | 3.02 Billion USD | -1.51% |
| 2012 Q2 | 3.06 Billion USD | -0.44% |
| 2012 Q1 | 3.08 Billion USD | 0.34% |
| 2011 Q2 | 2.98 Billion USD | 2.38% |
| 2011 Q1 | 2.91 Billion USD | -0.54% |
| 2011 Q3 | 3.02 Billion USD | 1.55% |
| 2011 FY | 3.07 Billion USD | 4.94% |
| 2011 Q4 | 3.07 Billion USD | 1.49% |
| 2010 Q1 | 2.92 Billion USD | -7.95% |
| 2010 Q2 | 2.94 Billion USD | 0.86% |
| 2010 Q3 | 2.91 Billion USD | -1.34% |
| 2010 Q4 | 2.92 Billion USD | 0.58% |
| 2010 FY | 2.92 Billion USD | -7.86% |
| 2009 Q4 | 3.17 Billion USD | -2.63% |
| 2009 FY | 3.17 Billion USD | -9.03% |
| 2009 Q2 | 3.38 Billion USD | -1.77% |
| 2009 Q1 | 3.44 Billion USD | -1.42% |
| 2009 Q3 | 3.26 Billion USD | -3.51% |
| 2008 Q4 | 3.49 Billion USD | 14.95% |
| 2008 FY | 3.49 Billion USD | 1239.99% |
| 2008 Q3 | 3.03 Billion USD | -2.1% |
| 2008 Q1 | 3.28 Billion USD | 1161.92% |
| 2008 Q2 | 3.1 Billion USD | -5.64% |
| 2007 Q2 | 213.25 Million USD | -11.45% |
| 2007 Q3 | 233.84 Million USD | 9.66% |
| 2007 FY | 260.62 Million USD | 4.06% |
| 2007 Q4 | 260.62 Million USD | 11.45% |
| 2007 Q1 | 240.83 Million USD | -3.84% |
| 2006 Q2 | 70.69 Million USD | 18.95% |
| 2006 Q3 | 118.7 Million USD | 67.91% |
| 2006 FY | 250.45 Million USD | 303.93% |
| 2006 Q4 | 250.45 Million USD | 110.99% |
| 2006 Q1 | 59.43 Million USD | -4.14% |
| 2005 Q3 | 60.76 Million USD | 12.27% |
| 2005 FY | 62 Million USD | 36.35% |
| 2005 Q4 | 62 Million USD | 2.04% |
| 2005 Q1 | 42.69 Million USD | -6.13% |
| 2005 Q2 | 54.12 Million USD | 26.78% |
| 2004 Q1 | 41.11 Million USD | 3.63% |
| 2004 FY | 45.47 Million USD | 14.62% |
| 2004 Q4 | 45.47 Million USD | 6.06% |
| 2004 Q3 | 42.87 Million USD | 4.31% |
| 2004 Q2 | 41.1 Million USD | -0.02% |
| 2003 Q3 | 38.12 Million USD | -2.01% |
| 2003 Q2 | 38.91 Million USD | 3.97% |
| 2003 Q1 | 37.42 Million USD | -10.6% |
| 2003 Q4 | 39.67 Million USD | 4.06% |
| 2003 FY | 39.67 Million USD | -5.23% |
| 2002 Q1 | 70.92 Million USD | -14.87% |
| 2002 Q4 | 41.86 Million USD | -37.28% |
| 2002 Q3 | 66.75 Million USD | -3.66% |
| 2002 FY | 41.86 Million USD | -49.75% |
| 2002 Q2 | 69.28 Million USD | -2.31% |
| 2001 Q2 | 84.9 Million USD | -0.25% |
| 2001 FY | 83.31 Million USD | -5.42% |
| 2001 Q4 | 83.31 Million USD | 8.98% |
| 2001 Q3 | 76.44 Million USD | -9.96% |
| 2001 Q1 | 85.11 Million USD | -3.37% |
| 2000 Q2 | 26.62 Million USD | -1.38% |
| 2000 Q4 | 88.08 Million USD | 214.69% |
| 2000 FY | 88.08 Million USD | 246.78% |
| 2000 Q1 | 27 Million USD | 6.3% |
| 2000 Q3 | 27.99 Million USD | 5.11% |
| 1999 Q3 | 27.8 Million USD | -3.14% |
| 1999 FY | 25.4 Million USD | -21.12% |
| 1999 Q4 | 25.4 Million USD | -8.63% |
| 1999 Q2 | 28.7 Million USD | -18.0% |
| 1999 Q1 | 35 Million USD | 8.7% |
| 1998 Q4 | 32.2 Million USD | 6.27% |
| 1998 Q3 | 30.3 Million USD | 17.9% |
| 1998 Q1 | 21.9 Million USD | 22.35% |
| 1998 FY | 32.2 Million USD | 79.89% |
| 1998 Q2 | 25.7 Million USD | 17.35% |
| 1997 Q3 | 18.5 Million USD | 2.78% |
| 1997 Q4 | 17.9 Million USD | -3.24% |
| 1997 FY | 17.9 Million USD | 13.29% |
| 1997 Q1 | 19.2 Million USD | 21.52% |
| 1997 Q2 | 18 Million USD | -6.25% |
| 1996 FY | 15.8 Million USD | 41.07% |
| 1996 Q4 | 15.8 Million USD | 13.67% |
| 1996 Q3 | 13.9 Million USD | 8.59% |
| 1996 Q2 | 12.8 Million USD | 6.67% |
| 1996 Q1 | 12 Million USD | 7.14% |
| 1995 Q3 | 11.2 Million USD | 20.43% |
| 1995 FY | 11.2 Million USD | 30.23% |
| 1995 Q1 | 8.8 Million USD | 2.33% |
| 1995 Q4 | 11.2 Million USD | 0.0% |
| 1995 Q2 | 9.3 Million USD | 5.68% |
| 1994 Q3 | 8 Million USD | 15.94% |
| 1994 FY | 8.6 Million USD | 45.76% |
| 1994 Q2 | 6.9 Million USD | 13.11% |
| 1994 Q1 | 6.1 Million USD | 3.39% |
| 1994 Q4 | 8.6 Million USD | 7.5% |
| 1993 FY | 5.9 Million USD | 28.26% |
| 1993 Q2 | 4.2 Million USD | 0.0% |
| 1993 Q3 | 4.8 Million USD | 14.29% |
| 1993 Q4 | 5.9 Million USD | 22.92% |
| 1992 Q1 | 2.9 Million USD | -6.45% |
| 1992 Q2 | 4.2 Million USD | 44.83% |
| 1992 FY | 4.6 Million USD | 48.39% |
| 1992 Q4 | 4.6 Million USD | -9.8% |
| 1992 Q3 | 5.1 Million USD | 21.43% |
| 1991 FY | 3.1 Million USD | -32.61% |
| 1991 Q4 | 3.1 Million USD | 0.0% |
| 1990 Q4 | 4.6 Million USD | 0.0% |
| 1990 Q2 | 2.5 Million USD | 0.0% |
| 1990 FY | 4.6 Million USD | -13.21% |
| 1989 Q4 | 5.3 Million USD | 0.0% |
| 1989 FY | 5.3 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | -3080.12% |
| AngioDynamics, Inc. | 112.08 Million USD | -3491.917% |
| AtriCure, Inc. | 147.76 Million USD | -2624.615% |
| Avinger, Inc. | 19.97 Million USD | -20058.222% |
| Azenta, Inc. | 351.22 Million USD | -1046.29% |
| BioLife Solutions, Inc. | 75.05 Million USD | -5264.352% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 1.994% |
| Daxor Corporation | 858.75 Thousand USD | -468716.593% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -24581.216% |
| Femasys Inc. | 9.4 Million USD | -42715.048% |
| GlucoTrack, Inc. | 1.7 Million USD | -235614.286% |
| Harvard Bioscience, Inc. | 64.29 Million USD | -6162.054% |
| ICU Medical, Inc. | 2.25 Billion USD | -78.534% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -96.947% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -49559.556% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -8136.835% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -609959.157% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -609959.157% |
| Masimo Corporation | 1.67 Billion USD | -140.115% |
| Microbot Medical Inc. | 3.82 Million USD | -105127.392% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -15954.264% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | -258.426% |
| Nephros, Inc. | 3.5 Million USD | -114830.06% |
| NovoCure Limited | 783.63 Million USD | -413.761% |
| NEXGEL, Inc. | 4.78 Million USD | -83967.655% |
| NEXGEL, Inc. | 4.78 Million USD | -83967.655% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | -4556.435% |
| OraSure Technologies, Inc. | 52.17 Million USD | -7616.487% |
| Pro-Dex, Inc. | 23.34 Million USD | -17147.14% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -24383.096% |
| Predictive Oncology Inc. | 6.14 Million USD | -65411.68% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -58718.493% |
| QuidelOrtho Corporation | 3.55 Billion USD | -13.179% |
| Repligen Corporation | 853.2 Million USD | -371.866% |
| Sanara MedTech Inc. | 29.28 Million USD | -13648.529% |
| STAAR Surgical Company | 102.73 Million USD | -3818.706% |
| Sharps Technology, Inc. | 3.85 Million USD | -104336.285% |
| Utah Medical Products, Inc. | 7.14 Million USD | -56247.096% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 1.227% |
| Jin Medical International Ltd. | 8.92 Million USD | -45012.554% |